About Us

Mr. Song Bin, General Manager of Shanghai Dahua Pharmaceutical Co., Ltd., stated: “WHO Prequalification will further expand our global market reach and influence, support the goals of the Family Planning 2020 initiative, and deliver effective, reliable and affordable contraceptive services for women in resource-limited settings.”

Levoplant  is the world’s second two-rod subdermal implant to obtain WHO Prequalification. Since 2007, the Bill & Melinda Gates Foundation has supported the company’s PQ application through FHI 360. The United Nations Population Fund (UNFPA) has signed a long-term supply agreement with the company to supply Levoplant to recipient parties. Following the prequalification, more aid agencies are able to select and procure this product for their donor-funded programmes.